WP
RMD icon

Woodline Partners’s ResMed RMD Stock Holding History

Woodline Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.62M Buy
8,295
+2,602
+46% +$539K 0.01% 858
2026
Q1 		$1.28M Buy
5,693
+3,024
+113% +$754K ﹤0.01% 854
2025
Q4 		$643K Buy
+2,669
New +$683K ﹤0.01% 881
2023
Q2 		– Sell
-113,986
Closed -$25M – 733
2023
Q1 		$25M Buy
113,986
+69,104
+154% +$15M 0.34% 89
2022
Q4 		$9.34M Buy
+44,882
New +$9.86M 0.13% 225
2020
Q2 		– Sell
-46,284
Closed -$6.82M – 181
2020
Q1 		$6.82M Buy
+46,284
New +$7.37M 0.49% 68

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Woodline Partners's RMD Position: Q2 2026 in Review

Woodline Partners increased its ResMed (RMD) stake by 46% in Q2 2026, buying an estimated $539K and bringing the position to 8,295 shares worth $1.62M. The position accounts for 0.01% of the portfolio, ranked #858.

Woodline Partners first reported a position in RMD in Q1 2020 and has held it in 6 quarters since. The position peaked at $25M in Q1 2023. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Woodline Partners held 8,295 shares of ResMed worth $1.62M as of Q2 2026.
  • Woodline Partners bought 2,602 ResMed shares in Q2 2026, an estimated $539K.
  • ResMed made up 0.01% of Woodline Partners's portfolio in Q2 2026, its #858 holding.
  • Woodline Partners first reported a position in ResMed in Q1 2020 and has held it in 6 quarters since.
  • Woodline Partners's ResMed position peaked at $25M in Q1 2023.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.